Moors & Cabot
ELAN icon

Moors & Cabot’s Elanco Animal Health ELAN Stock Holding History

Moors & Cabot’s Portfolio ELAN Stock Details ELAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-8,139
Closed -$200K – 987
2026
Q2 		$200K Sell
8,139
-451
-5% -$10.4K 0.01% 900
2026
Q1 		$206K Buy
+8,590
New +$210K 0.01% 853
2025
Q4 		– Sell
-10,250
Closed -$206K – 935
2025
Q3 		$206K Buy
+10,250
New +$172K 0.01% 829
2023
Q4 		– Sell
-16,650
Closed -$187K – 862
2023
Q3 		$187K Buy
16,650
+3,900
+31% +$45.3K 0.01% 759
2023
Q2 		$128K Sell
12,750
-9,233
-42% -$85.7K 0.01% 785
2023
Q1 		$207K Sell
21,983
-1,292
-6% -$15.2K 0.01% 746
2022
Q4 		$284K Sell
23,275
-5,950
-20% -$74.2K 0.02% 606
2022
Q3 		$363K Sell
29,225
-1,542
-5% -$27K 0.03% 501
2022
Q2 		$604K Buy
30,767
+125
+0.4% +$2.96K 0.04% 368
2022
Q1 		$799K Sell
30,642
-225
-0.7% -$5.99K 0.05% 346
2021
Q4 		$876K Buy
30,867
+275
+0.9% +$8.55K 0.05% 315
2021
Q3 		$977K Buy
30,592
+4,500
+17% +$151K 0.06% 287
2021
Q2 		$905K Buy
26,092
+3,900
+18% +$129K 0.06% 278
2021
Q1 		$656K Buy
22,192
+745
+3% +$22.9K 0.05% 333
2020
Q4 		$658K Buy
21,447
+1,830
+9% +$55.8K 0.06% 295
2020
Q3 		$548K Buy
19,617
+589
+3% +$14.9K 0.05% 314
2020
Q2 		$403K Buy
19,028
+6,378
+50% +$141K 0.04% 366
2020
Q1 		$281K Sell
12,650
-5,850
-32% -$160K 0.04% 391
2019
Q4 		$544K Buy
18,500
+6,450
+54% +$175K 0.05% 323
2019
Q3 		$323K Buy
+12,050
New +$362K 0.04% 425

Other funds holding ELAN

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Artemis Investment Management
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Douglas Lane & Associates
Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return
ASR Vermogensbeheer
ASR Vermogensbeheer Utrecht, Netherlands $10.1B AUM 30.4% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $61B AUM 26.91% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return
DDD Partners
DDD Partners Bellevue, Washington $1.75B AUM 20.59% 1-Year Est. Return

Moors & Cabot's ELAN Position: Q3 2026 in Review

Moors & Cabot sold out of Elanco Animal Health (ELAN) in Q3 2026, closing a stake of 8,139 shares — an estimated $200K sold.

Moors & Cabot first reported a position in ELAN in Q3 2019 and held it in 20 quarters. The position peaked at $977K in Q3 2021. 242 funds tracked by Wall St. Rank hold ELAN as of Q3 2026.

  • Moors & Cabot reported no remaining Elanco Animal Health position as of Q3 2026 after selling out during the quarter.
  • Moors & Cabot sold 8,139 Elanco Animal Health shares in Q3 2026, an estimated $200K.
  • Moors & Cabot first reported a position in Elanco Animal Health in Q3 2019 and held it in 20 quarters.
  • Moors & Cabot's Elanco Animal Health position peaked at $977K in Q3 2021.
  • 242 funds tracked by Wall St. Rank held Elanco Animal Health as of Q3 2026.

Based on Moors & Cabot's 13F filing for Q3 2026, filed 6 Nov 2026.